Navigation Links
Live Webinar: Paperless QC Micro Implemented by Talecris Biotherapeutics
Date:4/20/2010

Interactive event features implementation of MODA-EM™

Wayne, PA (PRWEB) April 20, 2010 -- MODA Technology Partners will offer a live, interactive Webinar on the benefits and value of implementing MODA-EM™, on Tuesday, May 11, 2010 at 11:00 AM ET (8:00 AM PT, 9:00 AM MT). The presentation will feature Marvin Thompson, Manager, Quality Operations at Talecris, and Bob Toal, Vice President at MODA.

Talecris is a global biotherapeutic and biotechnology company that discovers, develops, and produces innovative biotherapeutics for people with life-threatening disorders. Talecris utilizes MODA's mobile data acquisition platform to automate their quality control (QC) process for improved Environmental Monitoring (EM), Utility Testing, and Product Testing.

Common manual paper-based process steps still burden most QC Micro programs: paper scheduling, sharpie pen labeling of sample media, manual reconciliation, paper log book entry, and manual notification on deviations. These steps are labor-intensive, time consuming, and yield duplication of tasks and high error rates. Talecris' implementation of MODA-EM allows them to achieve the goal of a paperless, automated QC organization.

During this live, 60-minute Webinar, MODA and Talecris will discuss the following:

 
  • Paperless QC Process and MODA-EM
  • Scope of the Talecris QC Micro Program
  • Previous Processes and the Need for Automation
  • Key Requirements for New Solution and Selection Process
  • Implementation and Validation of MODA-EM
  • Current State and Plans for the Future

The Webinar is co-sponsored by heipha and Biotest.

To learn more and register, visit http://www.modatp.com/index.php/interactive-webinars

About MODA
More science. Less paper. MODA Technology Partners provides a mobile data acquisition platform that enables quality assurance and quality control organizations to automate their regulated manufacturing processes, including pharmaceuticals and consumer products. MODA's flagship software, MODA-EM™, is a paperless QC Micro solution that leverages mobile computing technology and advanced visualization tools for increased operational efficiency, improved quality, and reduced costs. MODA enables companies to advance their Green Initiatives by reducing and eventually eliminating the need for paper-based, labor-intensive environment monitoring programs. MODA is headquartered in Wayne, Pennsylvania, with office locations throughout North America and Europe. For more information, visit http://www.modatp.com.

About heipha and Biotest
heipha Dr. Müller GmbH is a member of the Biotest Group, a company that researches, develops, and manufactures pharmaceutical, biotherapeutic, and microbiology diagnostic products and has specialized in the areas of application of immunology and hematology. For nearly 40 years, heipha has been a leading manufacturer of high-quality culture media for microbial diagnostics, environmental monitoring, and sterility testing. It offers more than 600 different products used in the medical and pharmaceutical fields. heipha is based in Eppelheim (Heidelberg), Germany. For more information, visit http://www.heipha.com. Biotest is based in Dreieich (Frankfurt), Germany. For more information, visit http://www.biotest.com.

###

Read the full story at http://www.prweb.com/releases/2010/04/prweb3895284.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related biology technology :

1. Zeus Webinar: Bioabsorbable Polymers as Biomaterials
2. MODA Offers Paperless QC Micro Webinar Series on Automating Environmental Monitoring, Utility and Product Testing
3. ImClone Systems and Lonza Walkersville to Discuss Paperless QC Micro at PDA Annual Meeting
4. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
5. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
6. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
7. Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference
8. Microfluidic chambers advance the science of growing neurons
9. Quick microchip test for dangerous antibiotic resistant bacteria
10. GenoLogics Geneus Achieves GeneChip-compatible(TM) Status with the Affymetrix GeneChip(R) Microarray Platform
11. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... , February 4, 2016 ... a biotechnology acceleration company is pleased to provide the following ... --> Over the last 3 months we have ... securities purchase agreements exceeding $1,000,000. As a result, we have ... Mannin Research Inc. license agreement and expect that development to ...
(Date:2/4/2016)... February 4, 2016 Strasbourg, France ... Inc. --> Strasbourg, France , to ... PharmaVentures is pleased to announce that it acted as ... manufacturing unit in Strasbourg, France , to ... --> --> Transgene (Euronext: TNG), a ...
(Date:2/3/2016)... Ascendis Pharma A/S (Nasdaq: ASND ), ... TransCon technology to address significant unmet medical needs, today ... Leerink Partners Global Healthcare Conference Location: , Waldorf ... 2016 Time:  , 11:55am EST www.ascendispharma.com ... An audio webcast of this event will be posted ...
(Date:2/3/2016)... (PRWEB) , ... February 03, 2016 , ... ... remote Linux and Unix visualization solutions today announced the addition of a powerful ... allows users to see the current state of the remote Linux desktop or ...
Breaking Biology Technology:
(Date:1/11/2016)... CHICAGO , Jan. 11, 2016  higi, ... via nearly 10,000 retail locations, web and mobile, ... than $40 million from existing investors. ... will be devoted to further innovate higi,s health ... app and web portal – including expanding services ...
(Date:1/8/2016)... 8, 2016 NXTD ), a ... ® , a privately held leading direct seller of ... 5000 fastest-growing company announced that on December 31, ... million in Nxt-ID to develop a proprietary new wireless ... ® , a unique smart wallet that serves to ...
(Date:1/7/2016)... Jan. 7, 2016 Various factors have ... products such as biologics and biosimilars. Some of ... healthcare expenditure, growing demand for cost-effective alternatives, growing ... Biosimilars are similar versions of their corresponding patented ... their quality, safety, and efficacy. The global biosimilars ...
Breaking Biology News(10 mins):